vs

Side-by-side financial comparison of CAPRICOR THERAPEUTICS, INC. (CAPR) and Legacy Education Inc. (LGCY). Click either name above to swap in a different company.

Legacy Education Inc. is the larger business by last-quarter revenue ($19.2M vs $11.1M, roughly 1.7× CAPRICOR THERAPEUTICS, INC.). Legacy Education Inc. runs the higher net margin — 10.6% vs -63.9%, a 74.6% gap on every dollar of revenue. On growth, Legacy Education Inc. posted the faster year-over-year revenue change (40.7% vs -7.9%). Legacy Education Inc. produced more free cash flow last quarter ($512.7K vs $-15.3M).

Capricor Therapeutics is a clinical-stage biotechnology company focused on discovering, developing and commercializing innovative biological therapies including cell and gene therapies for rare diseases, cardiovascular disorders and muscular conditions. It primarily operates in the U.S. market, addressing unmet medical needs for patient groups with limited treatment options.

Legacy Education Inc. is a professional educational service provider focused on financial literacy, real estate investment, entrepreneurship, and personal wealth management training programs. It mainly serves individual learners across North America, Europe and select Asia-Pacific markets, offering both in-person workshops and online digital courses to help users build practical financial and business skills.

CAPR vs LGCY — Head-to-Head

Bigger by revenue
LGCY
LGCY
1.7× larger
LGCY
$19.2M
$11.1M
CAPR
Growing faster (revenue YoY)
LGCY
LGCY
+48.6% gap
LGCY
40.7%
-7.9%
CAPR
Higher net margin
LGCY
LGCY
74.6% more per $
LGCY
10.6%
-63.9%
CAPR
More free cash flow
LGCY
LGCY
$15.8M more FCF
LGCY
$512.7K
$-15.3M
CAPR

Income Statement — Q4 FY2024 vs Q2 FY2026

Metric
CAPR
CAPR
LGCY
LGCY
Revenue
$11.1M
$19.2M
Net Profit
$-7.1M
$2.0M
Gross Margin
Operating Margin
-69.1%
13.3%
Net Margin
-63.9%
10.6%
Revenue YoY
-7.9%
40.7%
Net Profit YoY
-833.8%
46.0%
EPS (diluted)
$-0.11
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAPR
CAPR
LGCY
LGCY
Q4 25
$19.2M
Q3 25
$19.4M
Q2 25
$18.0M
Q1 25
$18.6M
Q4 24
$11.1M
$13.6M
Q3 24
$2.3M
$14.0M
Q2 24
$4.0M
Q1 24
$4.9M
Net Profit
CAPR
CAPR
LGCY
LGCY
Q4 25
$2.0M
Q3 25
$2.2M
Q2 25
$1.2M
Q1 25
$2.8M
Q4 24
$-7.1M
$1.4M
Q3 24
$-12.6M
$2.1M
Q2 24
$-11.0M
Q1 24
$-9.8M
Operating Margin
CAPR
CAPR
LGCY
LGCY
Q4 25
13.3%
Q3 25
13.9%
Q2 25
11.1%
Q1 25
19.7%
Q4 24
-69.1%
12.2%
Q3 24
-575.2%
19.1%
Q2 24
-291.9%
Q1 24
-209.2%
Net Margin
CAPR
CAPR
LGCY
LGCY
Q4 25
10.6%
Q3 25
11.3%
Q2 25
6.8%
Q1 25
15.2%
Q4 24
-63.9%
10.3%
Q3 24
-555.2%
14.9%
Q2 24
-277.0%
Q1 24
-199.6%
EPS (diluted)
CAPR
CAPR
LGCY
LGCY
Q4 25
$0.15
Q3 25
$0.16
Q2 25
$0.07
Q1 25
$0.21
Q4 24
$-0.11
$0.10
Q3 24
$-0.38
$0.21
Q2 24
$-0.35
Q1 24
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAPR
CAPR
LGCY
LGCY
Cash + ST InvestmentsLiquidity on hand
$151.5M
$21.1M
Total DebtLower is stronger
$660.3K
Stockholders' EquityBook value
$145.5M
$46.1M
Total Assets
$170.5M
$73.1M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAPR
CAPR
LGCY
LGCY
Q4 25
$21.1M
Q3 25
$20.6M
Q2 25
$20.3M
Q1 25
$17.3M
Q4 24
$151.5M
$16.9M
Q3 24
$85.0M
$21.5M
Q2 24
$29.5M
Q1 24
$39.9M
Total Debt
CAPR
CAPR
LGCY
LGCY
Q4 25
$660.3K
Q3 25
$776.9K
Q2 25
$1.4M
Q1 25
$1.0M
Q4 24
$1.1M
Q3 24
$758.2K
Q2 24
Q1 24
Stockholders' Equity
CAPR
CAPR
LGCY
LGCY
Q4 25
$46.1M
Q3 25
$43.7M
Q2 25
$41.0M
Q1 25
$39.3M
Q4 24
$145.5M
$36.4M
Q3 24
$68.3M
$32.6M
Q2 24
$11.5M
Q1 24
$18.4M
Total Assets
CAPR
CAPR
LGCY
LGCY
Q4 25
$73.1M
Q3 25
$72.1M
Q2 25
$69.2M
Q1 25
$67.1M
Q4 24
$170.5M
$62.1M
Q3 24
$93.0M
$50.6M
Q2 24
$38.3M
Q1 24
$49.4M
Debt / Equity
CAPR
CAPR
LGCY
LGCY
Q4 25
0.01×
Q3 25
0.02×
Q2 25
0.03×
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.02×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAPR
CAPR
LGCY
LGCY
Operating Cash FlowLast quarter
$-14.8M
$1.1M
Free Cash FlowOCF − Capex
$-15.3M
$512.7K
FCF MarginFCF / Revenue
-137.3%
2.7%
Capex IntensityCapex / Revenue
4.4%
2.8%
Cash ConversionOCF / Net Profit
0.52×
TTM Free Cash FlowTrailing 4 quarters
$-41.2M
$4.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAPR
CAPR
LGCY
LGCY
Q4 25
$1.1M
Q3 25
$1.1M
Q2 25
$3.0M
Q1 25
$918.7K
Q4 24
$-14.8M
$659.0K
Q3 24
$-11.6M
$3.2M
Q2 24
$-12.3M
Q1 24
$-1.3M
Free Cash Flow
CAPR
CAPR
LGCY
LGCY
Q4 25
$512.7K
Q3 25
$809.7K
Q2 25
$2.9M
Q1 25
$596.6K
Q4 24
$-15.3M
$466.8K
Q3 24
$-11.7M
$2.9M
Q2 24
$-12.3M
Q1 24
$-1.9M
FCF Margin
CAPR
CAPR
LGCY
LGCY
Q4 25
2.7%
Q3 25
4.2%
Q2 25
16.2%
Q1 25
3.2%
Q4 24
-137.3%
3.4%
Q3 24
-515.2%
21.1%
Q2 24
-310.9%
Q1 24
-38.3%
Capex Intensity
CAPR
CAPR
LGCY
LGCY
Q4 25
2.8%
Q3 25
1.3%
Q2 25
0.5%
Q1 25
1.7%
Q4 24
4.4%
1.4%
Q3 24
0.4%
1.7%
Q2 24
1.5%
Q1 24
12.4%
Cash Conversion
CAPR
CAPR
LGCY
LGCY
Q4 25
0.52×
Q3 25
0.48×
Q2 25
2.45×
Q1 25
0.33×
Q4 24
0.47×
Q3 24
1.52×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons